Onkos Surgical, a Parsippany, NJ-based provider of surgical solutions for musculoskeletal oncology and orthopaedics, raised $15M in Series C funding.
The backers – part of an existing investor syndicate – were not disclosed.
The company intends to use the funds to accelerate research and development pipeline, expand its commercial footprint, and evolve its manufacturing capabilities.
Led by Co-Founder and CEO Patrick Treacy, Onkos Surgical is a provider of solutions for musculoskeletal oncology and complex orthopaedic procedures. Its personalized approach supports improved patient outcomes and experiences using the latest innovations in virtual surgical planning, 3D modeling and printing, implant design, and workflow optimization. More than 350 medical institutions in the US use Onkos’ innovative Precision Orthopaedics solutions.
The above investments support the company’s focus on delivering surgeon-driven and patient-inspired approaches to address three main clinical challenges of complex orthopaedic procedures – implant loosening, soft tissue failures, and infection.